Medtronic plc (LON: 0Y6X)
Market Cap | 91.45B |
Revenue (ttm) | 25.42B |
Net Income (ttm) | 3.30B |
Shares Out | n/a |
EPS (ttm) | 2.52 |
PE Ratio | 27.69 |
Forward PE | n/a |
Dividend | 2.18 (2.47%) |
Ex-Dividend Date | Dec 27, 2024 |
Volume | 3,556 |
Average Volume | 10,682 |
Open | 87.78 |
Previous Close | 88.37 |
Day's Range | 87.56 - 88.46 |
52-Week Range | 68.87 - 91.91 |
Beta | 0.85 |
RSI | 70.26 |
Earnings Date | Feb 18, 2025 |
About Medtronic
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accesso... [Read more]
Financial Performance
In 2024, Medtronic's revenue was $32.36 billion, an increase of 3.64% compared to the previous year's $31.23 billion. Earnings were $3.68 billion, a decrease of -2.18%.
Financial numbers in USD Financial StatementsNews
J&J Falls — While Boston Scientific, Medtronic Pop — After Strokes Sideline A Key Product
Johnson & Johnson stock skidded Wednesday after the company temporarily paused sales of its pulsed field ablation system.
Is Medtronic's Dividend Safe?
Medtronic: Scoop Up This Dividend Aristocrat On Sale Now
Kuros Biosciences USA, Inc. Announces an Exclusive Strategic Agreement with the Medtronic Spinal Division
Medtronic will act as the exclusive sales agent of MagnetOsTM for Kuros Biosciences USA, Inc. in mutually agreed upon sales territories for use in spine surgeries Kuros will work collaboratively to se...
Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference
GALWAY, Ireland , Jan. 6, 2025 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 43rd annual J.P. Morgan healthcare confere...
Medtronic: A Dividend Aristocrat That's Poised To Pop
2 Cheap Dividend Aristocrats to Buy for 2025
#Morningstar #DividendArtisocrats #StockInvesting These reliable dividend stocks look significantly undervalued today. 00:00 Introduction 00:39 Federal Realty Trust FRT 01:25 Medtronic MDT Susan Dziu...
My Best Dividend Aristocrats For January 2025
The ProShares S&P 500 Dividend Aristocrat ETF rocked a cool 4.85% gain in November, but it's giving up nearly half of its return this year in December. I present 3 strategies that can theoretically be...
Medtronic Stock Is Still A Great "Buy"
Financial writer predicts Medtronic's stock will rise due to recent product launches and improved margins, reaffirming a Buy rating for 2025.
Looking Into Medtronic's Recent Short Interest
Medtronic's (NYSE: MDT) short percent of float has fallen 16.13% since its last report. The company recently reported that it has 10.01 million shares sold short , which is 0.78% of all regular share...
Jim Cramer takes a closer look at the medtech space
'Mad Money' host Jim Cramer takes a closer look at Medtronic, Edwards, and Idexx.
Medtronic continues losses for seven straight sessions
Medtronic (MDT) shares continue to decline, but analysts are still bullish on the stock despite concerns about the company's bottom line.
Buy 1 December Aristocrat Of 67 From 38 With 'Safer' Dividends
"Dividend Aristocrats
Medtronic PLC (MDT) Announces Third Quarter Cash Dividend for Fiscal Year 2025
Medtronic PLC (MDT) Announces Third Quarter Cash Dividend for Fiscal Year 2025
Medtronic announces cash dividend for third quarter of fiscal year 2025
GALWAY, Ireland , Dec. 5, 2024 /PRNewswire/ -- The board of directors of Medtronic plc (NYSE: MDT) on Thursday, December 5, 2024, approved the company's cash dividend for the third quarter of fiscal y...
Acutus Medical announces workforce reduction by 70%
Acutus Medical (AFIB) to reduce workforce by 70% and focus on supporting Medtronic products.
Price Over Earnings Overview: Medtronic
Looking into the current session, Medtronic Inc. (NYSE: MDT) shares are trading at $85.62, after a 1.06% decrease. Over the past month, the stock fell by 4.53% , but over the past year, it actually i...
Medtronic: Guidance Raised, Solid Dividend, Shares Still A Bargain
Best Long-Term Investment Stocks to Buy
Some of the best long-term investment stocks include companies that are in good financial standing, have a low valuation and pay consistent dividends.
Should You Pick Medtronic Stock At $85?
Medtronic (NYSE: MDT) reported its Q2 fiscal 2025 results (fiscal ends in April) last week, with revenues and earnings exceeding the street estimates. The company reported revenue of $8.4 billion and ...
The Best Large-Cap Stocks to Buy
Large-cap stocks are key additions to any well-rounded portfolio, but how do you find the best ones? We take a closer look here.
Starbucks To Rally Around 13%? Here Are 10 Top Analyst Forecasts For Tuesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page . Stifel ra...
Medtronic receives FDA clearance for new InPen™ app, paving the way for its Smart MDI system launch with Simplera™ CGM
New Smart MDI system will be the first system to deliver real-time, personalized insights on when and how much to dose including for missed or inaccurate mealtime doses. GALWAY, Ireland , Nov. 20, 202...
Medtronic Q3 Earnings: A Solid Performance, But Bottom Line Still Needs Fixing
Medtronic plc reported Q2 earnings today, with revenues of $8.4bn, up 5% year-on-year, adjusted EPS of $1.26, supported by a dividend yielding 3.2%. Despite consistent mid-single-digit revenue growth ...
Gold Moves Higher; Medtronic Posts Upbeat Results
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite gaining by around 1% on Tuesday.